Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
CodeLab Capital AS is a Norwegian technology company specializing in the development of software tools primarily serving the healthcare sector. Founded in 2014 and headquartered in Trondheim, Norway, the company provides software development tools both within Norway and internationally, with a strong focus on health information services. Formerly known as PatientSky Group AS until its rebranding in May 2023, CodeLab Capital supports healthcare professionals by delivering electronic health record (EHR) solutions and compliance software related to occupational health, HSE (Health, Safety and Environment), and HACCP standards. Its offerings emphasize customized functionalities and close customer relationships, aiming to bridge the gap between patients and healthcare providers. In addition to software development, CodeLab Capital is actively involved in investing and strategy support for tech companies to foster sustainable growth and positive global impact. The company operates with a modest workforce of around 28 employees and maintains a significant role within Norway's healthcare technology landscape, extending its influence steadily in the Nordic and broader international markets.
NOK 0.28
NOK 0.00 (-1.40%)
EOD Jul 1, 2026
The business is unprofitable at the operating level (-149.23% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 4173.0% YoY with margins expanding 54484.4pp.
Negative free cash flow of -NOK 13M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
NOK 11M
▲ +4173.0% YoY
Net Income (TTM)
-NOK 15M
▲ +90.2% YoY
Op. Margin
-149.23%
▲ +54484.4pp YoY
ROIC
-49.64%
▲ +92.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-NOK 13M
▲ +81.0% YoY
Op. Cash Flow (TTM)
-NOK 13M
▲ +76.6% YoY
Net Debt
-NOK 11M
Net Cash Position
Cash & Equiv.
NOK 14M
3Y CAGR: -62.1%
Continue Research
CodeLab Capital AS (CODE.XOSL)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, CodeLab Capital AS scores 20/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
CodeLab Capital AS scores 20 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -149.2% operating margin and a -49.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh CODE.XOSL's valuation and scores 20/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.